Magle Chemoswed Holding AB (OSTO:MAGLE) Accounts Receivable: kr40.6 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:MAGLE Magle Chemoswed Holding AB OSTO:MAGLE
39 GF Score
Price kr0.44
GF Value kr23.42
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Magle Chemoswed Holding AB Accounts Receivable?

Magle Chemoswed Holding AB OSTO:MAGLE +14.14% 39 Accounts Receivable is kr40.6 Mil as of Jun. 2026. GuruFocus rates OSTO:MAGLE with a GF Score™ of 39/100 and a GF Value™ of kr23.42 (Possible Value Trap). The stock has 6 warning signs investors should review.

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Magle Chemoswed Holding AB's accounts receivables for the quarter that ended in Jun. 2026 was kr40.6 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Magle Chemoswed Holding AB's Days Sales Outstanding for the quarter that ended in Jun. 2026 was 50.78.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Magle Chemoswed Holding AB's Net-Net Working Capital per share for the quarter that ended in Jun. 2026 was kr-22.67.

Magle Chemoswed Holding AB Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Magle Chemoswed Holding AB's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=40.587/72.932*91
=50.78

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Magle Chemoswed Holding AB's accounts receivable are only considered to be worth 75% of book value:

Magle Chemoswed Holding AB's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2026 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(2.085+0.75 * 40.587+0.5 * 104.413-552.803
-0-0)/20.649
=-22.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Magle Chemoswed Holding AB Accounts Receivable Related Terms

Magle Chemoswed Holding AB Accounts Receivable Historical Data

* Premium members only.

The historical data trend for Magle Chemoswed Holding AB's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Magle Chemoswed Holding AB Accounts Receivable Chart

Magle Chemoswed Holding AB Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Receivable
Get a 7-Day Free Trial 25.24 14.46 18.70 38.63 38.99

Magle Chemoswed Holding AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.31 36.54 38.99 30.98 40.59
OSTO:MAGLE
39GF Score
Magle Chemoswed Holding AB OSTO:MAGLE
Accounts Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Magle Chemoswed Holding AB Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Frequently Asked Questions Learn more about Accounts Receivable →
What does a Accounts Receivable of kr40.6 Mil mean?
Magle Chemoswed Holding AB (OSTO:MAGLE) has a Accounts Receivable of kr40.6 Mil as of Jun. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Magle Chemoswed Holding AB and its competitors.
Is Magle Chemoswed Holding AB's Accounts Receivable too high?
Magle Chemoswed Holding AB's current Accounts Receivable is kr40.6 Mil. Overall, Magle Chemoswed Holding AB has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Magle Chemoswed Holding AB's Accounts Receivable compare to VRTX and REGN?
Magle Chemoswed Holding AB's Accounts Receivable of kr40.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Biotechnology company?
A good Accounts Receivable depends on the Biotechnology industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on Magle Chemoswed Holding AB and its competitors. Magle Chemoswed Holding AB's current Accounts Receivable is kr40.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Magle Chemoswed Holding AB stock overvalued right now?
Based on GuruFocus' analysis, Magle Chemoswed Holding AB (OSTO:MAGLE) is currently considered Possible Value Trap. The stock's GF Value™ is kr23.42, compared to a current price of kr0.44 — trading 98.1% below its estimated fair value. The current Accounts Receivable is kr40.6 Mil. Magle Chemoswed Holding AB's overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For Magle Chemoswed Holding AB (OSTO:MAGLE), the current Accounts Receivable is kr40.6 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Magle Chemoswed Holding AB (OSTO:MAGLE) Overvalued in 2026?

Based on GuruFocus' analysis, Magle Chemoswed Holding AB stock appears to be undervalued. The current stock price of kr0.44 is trading 98.1% below its estimated GF Value™ of kr23.42. GuruFocus considers Magle Chemoswed Holding AB to be Possible Value Trap.

Key valuation signals for OSTO:MAGLE:

  • Accounts Receivable: kr40.6 Mil
  • GF Value™: kr23.42 vs. price of kr0.44 (98.1% below fair value)
  • GF Score™: 39/100 with 6 warning signs

No single metric tells the full story. See the OSTO:MAGLE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Magle Chemoswed Holding AB Business Description

Other Exchanges 52X:Germany
Address Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.
39GF Score

Get the complete analysis for OSTO:MAGLE

Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.44
Price
kr23.42
GF Value